Metabolic Syndrome according to Three Definitions in Hammam-Sousse Sahloul Heart Study: A City Based Tunisian Study

Table 6

Prevalence of various profiles of MetS by age according to the 3 definitions.

Various profiles	IDF 2005 [7]		JIS 2009 [8]		NCEP ATP III 2001 [6]
	20–59 years %	60 years %	20–59 years %	60 years %	20–59 years %	60 years %
1	6.8	13.3	6.6	12.9	7.2	10
2	—	—	0.4	0.6	1.1	4
3	—	—	1.8	2.3	6.1	7.3
4	14.8	33.9	14.3	32.7	12.8	28
5	7.2	3	7	2.9	3.9	1.3
6	0.4	1.8	0.4	1.8	0	1.3
7	1.9	0.6	1.8	0.6	3.3	2
8	0.4	0	0.4	0	0.6	0.7
9	5.3	0	8.5	1.8	15	6.7
10	8.7	1.8	5.1	0	7.2	1.3
11	1.5	1.2	1.5	1.2	1.1	1.3
12	—	—	0.4	0	2.2	0
13	45.5	26.7	44.1	25.7	28.9	21.3
14	7.6	17.6	7.4	17	6.7	14
15	—	—	0	0.6	0.6	0
16	—	—	0.4	0	3.3	0.7
𝑃	<0.0001		<0.0001		<0.0001

1: higher WC + hypertriglyceridemia + hyperglycemia + low HDL-C + hypertension; 2: hypertriglyceridemia + hyperglycemia + low HDL-C + hypertension; 3: hyperglycemia + low HDL-C + hypertension; 4: higher WC + hyperglycemia + low HDL-C + hypertension; 5: higher WC + hypertriglyceridemia + low HDL-C + hypertension; 6: higher WC + hypertriglyceridemia + hyperglycemia + hypertension; 7: higher WC + hypertriglyceridemia + hyperglycemia + low HDL-C; 8: higher WC + hypertriglyceridemia + hyperglycemia; 9: higher WC + hyperglycemia + low HDL-C; 10: higher WC + hypertriglyceridemia + low HDL-C; 11: higher WC + hypertriglyceridemia + hypertension; 12: hypertriglyceridemia + hyperglycemia + low HDL-C; 13: higher WC + low HDL-C + hypertension; 14: higher WC + hyperglycemia + hypertension; 15: hypertriglyceridemia + hyperglycemia + hypertension; 16: hypertriglyceridemia + low HDL-C + hypertension.